Showing results (1251-1260 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|October 23, 2020
LRP1 polymorphisms associated with warfarin stable dose in Chinese patients: a stepwise conditional analysisDan Li, Hong Zhu, Zhi-Ying Luo, et al.
Pharmacogenomics|October 30, 2020
The inclusion of health data standards in the implementation of pharmacogenomics systems: a scoping reviewDon Roosan, Angela Hwang, Anandi V Law, et al.
Pharmacogenomics|October 30, 2020
Nonresponse to high-dose bupropion for depression in a patient carrying CYP2B6*6 and CYP2C19*17 variants: a case reportCéline K Stäuble, Markus L Lampert, Thorsten Mikoteit, et al.
Pharmacogenomics|October 29, 2020
Pharmacogenomics in the UK National Health Service: opportunities and challengesRichard M Turner, William G Newman, Elvira Bramon, et al.
Pharmacogenomics|September 28, 2022
Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosingSam Mostafa, Thomas M Polasek, Chad A Bousman, et al.
Pharmacogenomics|March 17, 2021
Pharmacogenomics of oxycodone: a narrative literature reviewNelly N Umukoro, Blessed W Aruldhas, Ryan Rossos, et al.
Pharmacogenomics|January 15, 2021
North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health CollaborativeJai N Patel, Deepak Voora, Gillian Bell, et al.
Pharmacogenomics|March 22, 2021
Venous thromboembolism and prostate cancer: what about genetic markers?Sofia Coelho Abreu, Valéria Tavares, Filipa Carneiro, et al.
Pharmacogenomics|November 8, 2021
HLA-DRB1*16:02 is associated with PEG-asparaginase hypersensitivityShuguang Liu, Chao Gao, Ying Wu, et al.
Pharmacogenomics|February 1, 2021
Potential of whole-genome sequencing-based pharmacogenetic profilingSylvan Manuel Caspar, Timo Schneider, Patricia Stoll, et al.
Pageof 276